Attention deficit hyperactivity disorder (ADHD) is one of the most common comorbidities in children with epilepsy but the mechanisms underlying their relationship are not clear. To determine whether an earlier age at seizure onset was associated with ADHD independent of other epilepsy-related factors, data from 203 children with epilepsy (6 to 17 years and 11 months; 53% female) were analyzed. The Diagnostic and Statistical Manual of Mental Disorders fifth edition helped define two groups: epilepsy without (n = 96) or with (n = 107) ADHD. The academic repercussions of ADHD were assessed using a composite school impact index. A binary logistic regression model was fitted considering the effects of age at seizure onset, type of epilepsy, frequency of seizures in the last 12 months, and number of antiseizure medication (ASM) on the ADHD diagnosis and their pairwise interactions. Around half of the children (52%) had a comorbid ADHD. The median school impact index was higher in children with epilepsy with vs without ADHD (33 vs 19%, p < 0.001). The age at seizure onset had a significant effect on ADHD diagnosis (OR = 0.99, 95% Confidence Interval = 0.96-1.01, p = 0.008) independent of other epilepsy-related factors. The risk of ADHD diagnosis decreased by 1% for each additional month of the age at seizure onset. To conclude, the risk of ADHD is higher when seizures begin earlier in life and ADHD exacerbates the adverse impact on school performance, underscoring the imperative for early systematic screening for ADHD from the first seizure.

The authors have declared no competing interest.

NCT03094793

This study did not receive any funding.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the French Comite de Protection des Personnes (Sud Est V) (COGNI-AIC-38RC14.374) and recorded on ClinicalTrials.gov (ID: NCT03094793).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The data supporting the results of this study are not publicly available due to ethical and privacy restrictions. The data may be available on request from the corresponding author, with the additional and documented consent of the patients and legal representatives involved in this study.